These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 168116)

  • 1. Combination effect of bis(3-methylsulfonyloxypropyl)amide and 6-mercaptopurine on AH-60C and AH-109A.
    Imamura H; Okumoto T
    Gan; 1975 Feb; 66(1):95-7. PubMed ID: 168116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of bis(3-methylsulfonyloxypropyl)-amine toluenesulfonate (864-T) with 6-mercaptopurine and other antitumor agents.
    Imamura H; Ikegami K; Okumoto T
    Gan; 1973 Oct; 64(5):427-31. PubMed ID: 4358730
    [No Abstract]   [Full Text] [Related]  

  • 3. Beta-glucuronidase activity of Yoshida ascites hepatomas of different drug-sensitivity and its change after treatment of host rats with various anticancer agents.
    Abe I; Sato S
    Gan; 1976 Feb; 67(1):55-65. PubMed ID: 57896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of 1,1'-polymethylene-bis (1-nitrosourea) and related compounds.
    Miyahara M; Nakadate M; Miyahara M; Suzuki I; Ishidate M; Odashima S
    Gan; 1977 Oct; 68(5):573-80. PubMed ID: 201535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor inhibitory effect of a new series of methanesulfonate of aminoglycols.
    el-Merzabani MM; Ichimura H; Sato H; Sakurai Y
    Gan; 1973 Dec; 64(6):591-7. PubMed ID: 4360584
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined effect of nitrogen mustard and DNA repair inhibitor on the resistant tumor.
    Inaba M; Sakurai Y
    Gan; 1974 Oct; 65(5):465-6. PubMed ID: 4373303
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapy of neoplasms].
    Osswald H
    Hippokrates; 1967 Jul; 38(13):497-506. PubMed ID: 5611578
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumor activity of improsulfan by the fractionated dose schedule on rat ascites tumors.
    Okumoto T; Imamura H
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2668-72. PubMed ID: 189948
    [No Abstract]   [Full Text] [Related]  

  • 9. [Time factor in evaluating antineoplastic agents].
    Syrkin AB
    Farmakol Toksikol; 1972; 35(1):75-9. PubMed ID: 5011523
    [No Abstract]   [Full Text] [Related]  

  • 10. Suggestive evidence for relationship between sensitivity and repair capability in rat ascites hepatoma cells treated with the antitumor agent, 1-(gamma-chloropropyl)-2-chloromethylpiperidine hydrobromide.
    Fukuda S; Koshiura R; Miyamoto K; Hatano M
    Gan; 1977 Apr; 68(2):175-82. PubMed ID: 196969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of established tumors and induction of tumor immunity by intratumor chemotherapy.
    Bast RC; Segerling M; Ohanian SH; Greene SL; Zbar B; Rapp HJ; Borsos T
    J Natl Cancer Inst; 1976 Apr; 56(4):829-32. PubMed ID: 176411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinostatic effect of 1,1'-polymethylenebis-(1-nitrosourea) on AH-13 and L-1210 cells.
    Nakadate M; Anzai M; Suzuki I; Ishidate M; Odashima S
    Gan; 1973 Aug; 64(4):415-6. PubMed ID: 4356566
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumor activity of a new amino acid derivative, N6,N9-bis-(butyloxycarbonylaminomethyl)-L-citrulline.
    Fujita H; Seto Y; Sakurai T; Ichimura H; Satoh H; Toyoshima S
    Gan; 1978 Feb; 69(1):99-101. PubMed ID: 205478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental study of antitumor action of rubomycin in combination with some cytostatic compounds].
    Rossolimo OK; Lepeshkina GN
    Antibiotiki; 1967 Mar; 12(3):206-12. PubMed ID: 4969789
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental findings concerning the antineoplastic drug fluordopan].
    Larionov LF; Bukharova IK
    Vopr Onkol; 1971; 17(5):78-81. PubMed ID: 4333111
    [No Abstract]   [Full Text] [Related]  

  • 16. [Spectrum of antineoplastic agents in ascites hepatoma--hypothesis on application of the results of animal experiments to human cancer in screening of antineoplastic agents].
    Sato H; Ichimura H
    Nihon Rinsho; 1971 Jul; 29(7):1818-26. PubMed ID: 4338289
    [No Abstract]   [Full Text] [Related]  

  • 17. Total tumor cell count and hematopoietic system of ah 109A-bearing rats treated with mitomycin C and carboquone.
    Himori T; Ujiie S; Mimata Y; Sugiyama Z; Wakui A
    Sci Rep Res Inst Tohoku Univ Med; 1982 Dec; 29(1-4):77-86. PubMed ID: 6308758
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination chemotherapy with anticancer agents and OK-432.
    Kimura I; Onoshi T; Takano J; Osawa H; Yasuhara S
    Acta Med Okayama; 1974 Dec; 28(6):411-21. PubMed ID: 4142360
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea on experimental tumors.
    Hisamatsu T; Uchida S
    Gan; 1977 Dec; 68(6):819-24. PubMed ID: 202535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of amino acid derivatives in the primary screening.
    Fukushima K; Toyoshima S
    Gan; 1975 Feb; 66(1):29-36. PubMed ID: 168114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.